CSL362, a monoclonal antibody to CD123 demonstrated significant, antibody-dependent cell mediated cytotoxicity against AML blasts and was highly effective in reducing the leukemic burden in AML xenograft mouse models [18]. Here, IL3RA is linked to acute myeloid leukemia.